Cure My Disease

Don't miss your cure!

Log in / Sign up

IDH-mutant and 1p/19q-codeleted oligodendroglioma

MONDO:0859592

An anaplastic oligodendroglioma that has material basis in IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).

2831 clinical trials for this condition and its sub-types, 9 tagged with IDH-mutant and 1p/19q-codeleted oligodendroglioma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Anaplastic oligodendroglioma (35)

Sub-types of IDH-mutant and 1p/19q-codeleted oligodendroglioma

Including sub-types (2831) Tagged with IDH-mutant and 1p/19q-codeleted oligodendroglioma (9)

Trials to join now! 2 Not yet recruiting 4 Not yet finished but already full! 1 Completed 2

Can a targeted pill slow brain tumor growth after surgery?

Disease control Approved

This expanded access program offers vorasidenib, an oral drug, to people aged 12 and older with IDH-mutated glioma who have had surgery. The drug targets specific genetic mutations in tumor cells. The goal is to see if it can help control the disease without immediate need for ra…

Sponsor: Servier • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC